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ABSTRACT
Introduction: Cyclodextrins (CD), are known to form inclusion complexes with a variety of guest mol-
ecules both in solution and in the solid state. This can lead to the alteration of properties of guest mol-
ecules. Unfortunately, the complexation efficiency of CD is rather low, and can be enhanced by forma-
tion of ternary complexes using aminoacids (AA). Sulfadiazine (SDZ) is an antibiotic with extremely low 
water solubility which limits its therapeutic applications and bioavailability.
Objetives: The aim of this work was to increase the aqueous solubility of SDZ by preparing ternary 
complexes of this drug with β-cyclodextrin (βCD) and an AA as a third auxiliary substance.
Materials y Methods: Complex formation was studied by phase solubility analysis (PSA), nuclear mag-
netic resonance (NMR), differential scanning calorimetry (DSC), thermogravimetric analysis (TG) and 
scanning electron microscopy (SEM).
Results: The apparent stability constants (KC) of the multicomponent complexes were calculated from 
the solubility diagrams. By the analysis of the NMR spectra, it could be said that the shifts of some pro-
tons evidenced the important role of the AA in the formation of multicomponent complexes. Among the 
AA, Arginine (ARG) proved to have better solubilizing properties for SDZ, reaching an improvement 
up to 70 times. The use of DSC, TG and SEM suggested the formation of new solid phases between 
SDZ:βCD:AA.
Conclusions: As a result of this research, it was determined that ternary products were more effective in 
improving drug solubility than the corresponding SDZ:βCD binary system.
Keywords: sulfadiazine; complexation; β-cyclodextrin; ternary systems; aminoacid.
RESUMEN
Introducción: Las ciclodextrinas (CD), son capaces de formar complejos de inclusión con una variedad 
de moléculas huésped, tanto en solución y en estado sólido, pudiendo producir la modificación de las 
propiedades de las moléculas huésped. Desafortunadamente, la eficiencia de la formación de comple-
jos con CD es baja, lo cual se puede mejorar mediante la formación de complejos ternarios utilizando 
aminoácidos (AA). Sulfadiazina (SDZ) es un antibiótico con muy baja solubilidad en agua que limita su 
biodisponibilidad y sus aplicaciones terapéuticas.
Objetivos: El objetivo de este trabajo fue aumentar la solubilidad acuosa de SDZ mediante la prepara-
ción de complejos ternarios con β-ciclodextrina (βCD) y un AA como una tercera sustancia.
Materiales y Métodos: La formación de complejos se estudió por análisis de solubilidad de fases (PSA), 
resonancia magnética nuclear (RMN), calorimetría diferencial de barrido (DSC), análisis termogravimé-
trico (TG) y microscopía electrónica de barrido (SEM).
Resultados: Las constantes de estabilidad aparente (KC) de los complejos multi-componentes se cal-
cularon a partir de los diagramas de solubilidad. Por el análisis de los espectros de RMN se constató, 
por los corrimientos de algunos protones, el papel importante de los AA en la formación de complejos 
ternarios. Entre los AA, arginina (ARG) demostró tener mejores propiedades de solubilización para SDZ, 
alcanzando una mejora de hasta 70 veces. El uso de DSC, TG y SEM sugirió la formación de nuevas fases 
sólidas entre SDZ:βCD:AA.
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Conclusiones: Como resultado de esta investigación, se determinó 
que los productos ternarios fueron más eficaces en la mejora de la 
solubilidad del fármaco que el sistema binario SDZ: βCD.
Palabras Claves: sulfadiazina; complejación; β-ciclodextrina; siste-
mas ternarios; aminoacidos.
INTRODUCTION
CD (Fig. 1A), cyclic oligosaccharides joined through 1-4 
bonds,1 are known to form inclusion complexes with a va-
riety of guest molecules. This can lead to the alteration of 
physical, chemical and biological properties of guest mol-
ecules, and can eventually have considerable pharmaceuti-
cal potential. Thus, the hydrophilic CD have been exten-
sively used to enhance the oral bioavailability of several 
drugs. These improvements are mainly ascribable to the in-
crease in solubility and wettability of the drugs through the 
formation of inclusion complexes.2 Unfortunately, the com-
plexation efficiency of CD is rather low, and consequently 
significant amounts of these oligosaccharides are needed to 
solubilize small amounts of water-insoluble compounds. 
However, enhanced CD solubilizing capacity can be ob-
tained by formation of ternary complexes between a drug 
molecule, a CD molecule and a third component.3 Among 
the different strategies used for this purpose, studies car-
ried out in our laboratory have demonstrated that the 
solubility capacity of the CD was significantly enhanced 
when ethanolamines, meglumine and aminoacids were in-
corporated as ternary components in the complexes.4-8 On 
the other hand, other works showed that the addition of 
aminoacids can increase the solubilizing and complexing 
abilities of CD by multicomponent complex formation.9,10
SDZ (Fig. 1B) is derived from sulfanilamide, which is simi-
lar in structure to para-aminobenzoic acid (PABA), a factor 
required by bacteria for folic acid synthesis. SDZ competi-
tively inhibits dihydropteroate, the bacterial enzyme that is 
responsible for the incorporation of PABA into dihydrofolic 
acid, the immediate precursor of folic acid.11-13 A drawback, 
which restricts the application of this compound, is its ex-
tremely low water solubility (only about 0.074 mg/ml at 
25°C),14 which limits its therapeutic applications and bio-
availability.
Studies involving the complexation of SDZ with CD in bi-
nary systems have been reported in the literature, including 
our previous results.15-17 These investigations have demon-
strated that using complexation with CD (βCD, HPβCD or 
MβCD) can improve the aqueous solubility of SDZ. Also, a 
clear influence of the complex preparation methods on the 
drug dissolution behavior was observed.16 In this context, it 
seemed of interest to continue our studies on new types of 
drug carriers by obtaining ternary complexes of SDZ and 
βCD with the addition of AA such as glycine (GLY), leu-
cine (LEU), aspartic acid (ASP), glutamic acid (GLU) and 
ARG, as a strategy to improve the CD solubilizing power. 
The hypothesis of improving the physicochemical proper-
ties of SDZ by combination with different AA and CD was 
investigated. Based on this drug is an ampholyte, and in 
aqueous solutions can exist in the protonated, neutral and 
anionic forms we studied the interaction of sulfadiazine 
with various AA including acid and basic ones. A complete 
characterization of the systems in the aqueous solutions 
was carried out using phase solubility analysis (PSA) and 
NMR and 2D ROESY. The solid ternary systems prepared 
by different techniques, were also evaluated by DSC, TG, 
and SEM.
Fig.1. Chemical structure and proton atom numbering 
scheme of: (A) β-cyclodextrin, (B) Sulfadiazine, (C) Glycine, 
(D) Arginine and (E) Glutamic acid.
MATERIALS AND METHODS
Materials
SDZ was obtained from Parafarm (Buenos Aires, Argen-
tina). D2O 99.9 atom % D used in spectroscopic studies, 
L-Leucine and L-Arginine were purchased from Sigma®. 
L-Aspartic Acid and L-Glutamic Acid were obtained from 
Anedra (Buenos Aires, Argentina). Glycine was purchased 
from Todo Droga (Córdoba, Argentina) and βCD was a gift 
from Ferromet S.A. [agent in Argentina of Roquette (Lest-
rem, France)].
The water used in these studies was generated with a Milli-
Q Water Purification System (Millipore® Bedford, USA). All 
other chemicals and solvents used were of analytical grade.
169Ars Pharm. 2016; 57(4): 167-176
Studies of ternary systems of sulfadiazine with β-cyclodextrin and aminoacids
Phase solubility analysis (PSA)
Solubility diagrams were obtained according to Higu-
chi and Connors.18 These studies were done using excess 
amounts of SDZ either with constant quantities of βCD (4.2 
mM) and different concentrations of the AA: LEU (0-138 
mM), GLY (0-55.7 mM), ARG (0-179 mM), ASP (0-37 mM) 
and GLU (0-37 mM), or with constant amounts of the AA: 
LEU (28 mM), ARG (28 mM), GLU (7.5 mM), ASP (7.5 mM) 
and GLY (28 mM) and different concentrations of βCD (0-
12.0 mM). Then, the resulting suspensions were sonicated 
in an ultrasonic and placed in a 25.0±0.1ºC thermostatized 
water bath for 72 h. After equilibrium was reached, the sus-
pensions were filtered through a 0.45 µm membrane filter 
(Millipore®, USA) and analysed by UV–Vis spectrophotom-
etry (Shimadzu UV 260 UV-visible spectrophotometer) at 
264 nm. Each experiment was repeated at least three times 
and the results reported were the mean values. The ap-
parent stability constant (KC) values for the corresponding 
SDZ:CD:AA systems were calculated from the slope of the 
phase-solubility diagrams and S0 (solubility of SDZ at 25 
ºC in absence of complexing agents) according to equation 
(1)18:
Nuclear Magnetic Resonance Studies (1H NMR)
All experiments were performed on a Bruker Advance II 
High Resolution Spectrometer. Spectra were measured at 
400.16 MHz and 298 K using D2O, with the chemical shift 
of the residual solvent at 4.8 ppm being used as an internal 
reference. Induced changes in the 1H chemical shifts (∆δ) 
for βCD, AA and SDZ were originated from their complex-
ation, and calculated using the following equation (Eq. 2):
where δ0 and δc are the chemical shifts of the pure com-
pounds and the ternary complexes, respectively.
Positive and negative signs refer to downfield and upfield 
shifts, respectively.
Two-dimensional Rotating Frame Overhauser Experi-
ments (2D ROESY)
Drug and AA inclusion in the βCD cavity was studied by 
2D ROESY. Pulse sequence: roesygpph19; 2D ROESY with 
cw spinlock for mixing; phase sensitive and water sup-
pression using 3-9-19 pulse sequence with gradients; p15 
(f1 channel), pulse for ROESY spinlock (200000 usec); d1:2 
sec, d19 (delay for binomial water suppression), d19 = (1/
(2*d)), d = distance of next null (in Hz) use gradient ratio: 
gp 1:gp 2 (30:30); for z-only gradients: gpz1: 30%; gpz2: 30% 
use gradient files; gpnam1: SINE.100, gpnam2: SINE.100. 
Before Fourier transformation, the matrix was zero filled to 
4096 (F2) by 2048 (F1), and Gaussian apodization functions 
were applied in both dimensions. A ROESY experiment is 
suitable for obtaining information about the spatial proxim-
ity between the atoms of the host and the guest molecules 
by observing the intermolecular dipolar cross-correlations.
Preparation of the SDZ:βCD:AA systems in the solid 
state
The ternary systems (SDZ:βCD:AA) were prepared with 
equimolar ratios of SDZ, βCD and ARG, GLU or GLY. 
The physical mixtures were prepared by the simple mix-
ing of the components, while the co-evaporation systems 
by mixing and dissolving the corresponding components, 
in ethanol:water (1:1) mixtures, and removing the solvent 
with ultrasound. In freeze-drying systems, the components 
were suspended in distilled water, and then sonicated un-
til complete dissolution of the drug. Solutions were frozen 
before the freeze-drying was started (Freeze Dye 4.5 Lab-
conco corp., Kansas City, MI). Also, the pure compounds 
were lyophilized prior to DSC, TG and PXRD studies.
Differential scanning calorimetry (DSC) and Thermo-
gravimetric analysis (TG)
The DSC analyses were carried out with a DSC TA 2920 
using a heating rate of 10°C/min from 25 up to 350°C and 
under a nitrogen flow.
The TG curves were obtained using a TG TA 2950 under 
the same conditions as those of DSC.
Scanning electron microscopy (SEM) studies
The microscopic structures were investigated using a scan-
ning electron microscope LEO Model EVO 40XVP. The 
samples were fixed on a brass stub using double-sided alu-
minum tape, which were then made electrically conductive 
by coating with gold.
RESULTS AND DISSCUSION
Phase solubility analysis (PSA)
The PSA were performed with SDZ and increasing concen-
trations of each AA. It was observed that with LEU, GLY, 
ASP and GLU, the addition of the AA did not change the 
SDZ solubility and therefore its concentration in solution. 
This behavior suggested that the drug was found in its 
solubility limit in the range of the AA concentrations stud-
ied, leading to think that no interaction occurred between 
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them. However, an interaction between SDZ and ARG was 
observed since an increase in the solubility value to 27.25 
mg/ml was achieved. The KC value from the linear solubil-
ity isotherm was also determined following the method of 
Higuchi and Connors.18 Intrinsic solubility (S0), maximum 
solubility (Smax), and solubility efficiency (ES, Smax/S0) val-
ues were determined from PSA and are presented in Table 
1. Since by the presence of ARG were observed fluctuations 
in the pH values of the solutions (around 8) during the pro-
cess, and in order to conduct the study at the same pH, the 
PSA was carried out using a buffer solution of pH 8.
Then, the affinity of the drug for both the βCD and the AA, 
was determined by PSA in water. In an initial screening, the 
influence of changes in the concentration of the AA with 
βCD constant and SDZ in excess was evaluated. No varia-
tions were observed in the aqueous solubility of the drug, 
except for ARG (Table 1). When this AA was added as a 
third component, a higher enhancement in the solubility of 
SDZ was obtained in comparison with the binary complex 
(SDZ:βCD) as a result of the potential ability of the basic 
aminoacid to simultaneously interact with both the βCD 
and the drug. Also, a higher enhancement in the KC for the 
ternary SDZ:βCD:ARG complex was obtained in compari-
son with both binary systems (SDZ:ARG and SDZ:βCD), as 
shown in Table 1.
Finally, in a further attempt to improve the solubilizing and 
complexing ability of βCD, phase-solubility studies of the 
drug were performed in the presence of increasing concen-
trations of βCD with a constant concentration of the AA. 
In all ternary systems with aminoacids, the isotherms were 
linear within the βCD concentration ranges studied, with 
all the slopes less than 1, except for ARG. The KC values 
obtained (Table 1) showed that the binding of SDZ with 
βCD in the presence of GLU was relatively lower than with 
the other AA or βCD alone. These findings suggest that the 
presence of GLU weakens the interaction between SDZ and 
βCD. Nevertheless, it is interesting to note that the solubil-
ity of the drug in the ternary system with this AA increases 
to 0.678 mg/ml due to the formation of a highly soluble 
complex. This event can be explained by the higher initial 
solubility of the drug due to the increased ionization in the 
presence of GLU, with a consequent decrease in affinity for 
the apolar cavity of the βCD. The same reasoning could be 
applied to justify the increase in solubility caused by the 
presence of ASP as both AA, GLU and ASP, have one of the 
carboxylic acid groups ionized at the pH of the determina-
tions.
Although the KC values for the SDZ:βCD:LEU and 
SDZ:βCD:GLY systems were greater and lower, respective-
ly, than that of SDZ:βCD, the solubility results were very 
similar for the three systems.
Table 1: Data from the phase solubility analysis of SDZ with βCD and different AA
System Solvent finalpH KC (M-1) S0 (mg/ml) Smax (mg/ml) ES
SDZ:βCD water 5.96 282 ± 11 0.073 ± 0.009 0.33 ± 0.02 4
SDZ:ARG Buffer solution pH 8 8.77 395 ±6 0.90 ±0.06 27.2 ±0.5 30
SDZ: βCD:ARG water 8.49 1156 ±94 0.073 ±0.009 13.18 ±0.03 70
SDZ:βCD:GLI water 5.78 258.4 ± 0.3 0.073 ± 0.009 0.40 ± 0,09 5
SDZ:βCD:LEU  water 6.14 389 ± 7 0.073 ± 0.009 0.32 ± 0.01 4
SDZ:βCD:ASP  water 3.19 105 ± 5 0.073 ± 0.009 0.62 ± 0.01 8
SDZ:βCD:GLU  water 3.45 122 ± 7 0.073 ± 0,009 0.68 ± 0.04 9
1H NMR Studies
1H NMR spectroscopy is an analytical tool frequently used 
to study the inclusion of guest molecules in a host.19 be-
cause this fact modifies the environment of both, the in-
cluded protons of the guest moiety and those of the host 
cavity.
It is well known that βCD has the topology of a hollow cone 
shape, with the H3 and H5 being inner protons.20
The inclusion of SDZ and the AA in the βCD cavity was 
first evaluated by the changes in the chemical shifts (δ) of 
the protons in the complex regarding the free entities. For 
the NMR studies, ARG, GLU and GLY as model AA were 
selected. Table 2 presents the assignments of the SDZ, AA 
and βCD peaks and the chemical shift deviations (Δδ) due 
to complexation (see numbering of proton in Fig. 1).
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The upfield shifts observed for H5 and H3 protons of βCD, 
localized at the internal surface of the cavity, showed the 
presence of host-guest interactions for the SDZ:βCD:GLY 
system. The chemical shifts corresponding to the protons 
located on the external surface of βCD (H1, H2 and H4) 
were also modified. In the presence of βCD and GLY, all 
SDZ protons were shifted downfield, with the exception 
of Ha that was shifted upfield. GLY protons were shifted 
downfield.
However, when βCD was in the presence of the drug 
and ARG, as a third component, a small shift for H3 and 
a downfield displacement for H5 were only produced. In 
addition, the δ corresponding to the protons located at the 
outer surface of βCD (H1, H2 and H4) were also modified. 
As for SDZ, deshielding effects were observed for Hb, Hc 
and Hd but upfield shifts for Ha. Downfield effects were 
found for all ARG protons.
Also, downfield displacements were found for H3 and 
H5 of βCD in the SDZ:βCD:GLU complex. As in the cases 
above, the δ of the three external protons of βCD were also 
modified and downfield effects for Hb, Hc and Hd, and an 
upfield effect for Ha of SDZ were observed. Upfield shifts 
were found for all GLU protons.
The downfield shifts observed for H3 and H5 of βCD when 
GLU was present, and only for H5 when using ARG, could 
be attributed to the weak interactions (van der Waals force) 
between the hydrogen atoms of the internal cavity of the 
βCD with the drug or the AA. Differences were observed 
between the binary 16 and the ternary complexes. In the for-
mer case, a higher displacement was observed for H3, while 
in the latter case, the H5 showed the greatest displacement. 
On the other hand, the upfield shifts observed for both in-
ternal protons of βCD when GLY was present, were also 
evidence of host-guest interactions. These last shifts are 
probably due to the anisotropic currents produced by the 
aromatic ring of SDZ, which can indicate the deep penetra-
tion of the drug into the CD cavity.
The formation of a complex by inclusion is clearly evi-
denced by these spectral changes of the inner protons H3 
and H5 of βCD in the presence of both, the drug and the 
AA. Furthermore, the shifts observed for the protons locat-
ed on the outer surface of the oligosaccharide, may be due 
to a conformational arrangement of the guest molecule 16 or 
an effect produced by the presence of the AA.
Also, the upfield shift showed by the Ha of the drug is due 
to its association with the oxygen atoms of the CD, rich in π 
electrons, while the downfield shifts observed for the oth-
er protons are probably caused by a variation of the local 
polarity or by the deshielding effect produced by the Van 
der Waals forces between the drug and the carbohydrate 
chains.
Continuing with the analysis of the NMR spectra, it could 
be said that the shifts of the protons belonging to the AA 
suggest the involvement of them in the interactions be-
tween the βCD and SDZ, evidencing the important role of 
these AA in the formation of multicomponent complexes.
ROESY Experiments
2D ROESY experiments were carried out to investigate the 
inclusion of SDZ and/or AA in the βCD cavity. ARG, GLU 
and GLY were also used as third components for these stud-
ies. Figure 2 shows the partial contour plots of 2D ROESY 
spectra for the studied systems. In the SDZ:βCD:GLY sys-
tem (Fig. 2A), cross-peaks were observed between Ha of 
SDZ and some protons of βCD (H5 and H6) as well as be-
tween Hb and H3, H5, and H6, indicating the formation 
of an inclusion complex in which the ring A of SDZ was 
deeply inserted into the hydrophobic cavity of the host. 
Furthermore, H1 of GLY correlated with Ha and also with 
Hb of SDZ, but the latter with a low intensity.
However, in the 2D ROESY of SDZ:βCD:ARG (Fig. 2B), Ha 
and Hb of the drug correlated with the inner proton H5 
and with H6 of βCD, and also with H3 of ARG. As in the 
previous case, the formation of a complex was postulated 
through the insertion of the aromatic ring A of SDZ into 
the host cavity. In addition, the interaction of ARG with the 
drug was observed.
Finally, in the SDZ:βCD:GLU system (Fig. 2C), it was also 
observed the insertion of the drug in the CD cavity through 
the ring A since Ha of SDZ correlated with H5 and H6 of 
βCD. However, no interaction with GLU was observed.
The evaluation of the interaction of SDZ with each AA in 
the presence of βCD by 2D ROESY confirmed that there are 
associations between them, and that they contribute to the 
formation of ternary complexes.
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Differential scanning calorimetry (DSC) and Thermo-
gravimetric analysis (TG)
The DSC and TG curves of pure compounds and the three 
ternary systems are shown in Fig. 3 (A, B and C). The ther-
mal curve of SDZ showed a sharp fusion endothermic event 
occurring at 263 °C, corresponding to the melting point of 
the drug, followed by an exothermic event attributed, on 
the basis of TG results, to its thermal decomposition. As 
observed in TG curves, βCD loses water at temperatures 
between 25 and 100 °C, with decomposition above 300° C. 
The three AA show sharp endothermic melting peaks oc-
curring at 220, 252 and 208 °C for ARG, GLY and GLU, re-
spectively, followed by decomposition, which is consistent 
with the observations by TG.
Fig.2. Partial contour plot of the 2D ROESY spectrum of: (A) SDZ:βCD:GLY 
system, (B) SDZ:βCD:ARG system and (C) SDZ:βCD:GLU system.
When analyzing the physical mixtures with the three stud-
ied AA, we found the same characteristic events observed 
for each of the pure compounds. Therefore, no inclusion 
complexes were obtained. However, in the solids obtained 
by both co-evaporation and freeze-drying, the disappear-
ance of the SDZ melting point in all products suggests the 
formation of true inclusion complexes. Furthermore, the 
endothermic peak assigned to the dehydration of the βCD 
shifted to lower temperatures with respect to the pure βCD. 
This fact can be attributed to a weak interaction of the wa-
ter molecules with the βCD due to a better integration of 
this oligosaccharide with the SDZ and/or AA.
174 Ars Pharm. 2016; 57(4): 167-176
Alicia Delrivo, Ariana Zoppi, Gladys Granero, Marcela Longhi
Scanning electron microscopy (SEM)
SEM microphotographs of raw material (SDZ, βCD and AA) 
and ternary solid systems: SDZ:βCD:GLY, SDZ:βCD:ARG, 
SDZ:βCD:GLU are reported in Figure 4.
SDZ was present as a series of joined acicular crystals. βCD 
exhibited three-dimensional parallelogram crystals of ir-
regular size, while GLY (Fig. 4 C) was composed of large 
plate-like crystals with irregular borders. ARG (Fig. 4 G) 
showed a plate with minute round crystals and GLU (Fig. 4 
K) consisted of parallelograms of irregular size.
In all cases, the physical mixtures showed particles of βCD 
embedded in SDZ, AA and morphologies comparable with 
those of the pure compounds, revealing no apparent inter-
action between the species in the solid state. In contrast, 
freeze-drying products appeared to be of a lesser crystal-
Fig.3. DSC and TG curves of: (A) βCD (silver), GLY (green), GLY FD (olive), SDZ (pur-
ple), SDZ:βCD:GLY PM (blue), SDZ:βCD:GLY CO (red) and SDZ:βCD:GLY FD (black). 
(B) βCD (silver), ARG (green), ARG FD (olive), SDZ (purple), SDZ:βCD:ARG PM (blue), 
SDZ:βCD:ARG CO (red) and SDZ:βCD:ARG FD (black). (C) βCD (silver), GLU (green), 
GLU FD (olive), SDZ (purple), SDZ:βCD:GLU PM (blue), SDZ:βCD:GLU CO (red) and 
SDZ:βCD:GLU FD (black).
line structure with shapes and sizes completely different 
from those of free raw materials. Thus, it was not possible 
to differentiate the components demonstrating an appar-
ent interaction in the solid state, which might be indicative 
of the presence of a new solid phase. Finally, the presence 
of particles of pure components mixed with particles of 
different morphologies can be observed in the micropho-
tographs of the systems prepared by co-evaporation. This 
may be attributed to incomplete complex formation. In 
conclusion, the drastic changes in the particle shape and as-
pect in freeze drying products indicate the presence of new 
solid phases. Although the SEM technique is inadequate to 
conclude genuine complex formation, the obtained micro-
photographs support the idea of the achievement of three 
new components.
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CONCLUSIONS
On the basis of the physicochemical characterization tech-
niques described in this work, the complex formation be-
tween SDZ, βCD and aminoacids (GLY, GLU, ARG, ASP 
and LEU) was confirmed. Both the stoichiometry and equi-
librium constants for the inclusion complexes were evalu-
ated by the phase solubility method. ARG and GLU proved 
to have better solubilizing properties for SDZ than the other 
AA, as could be determined by the higher solubility values 
obtained for both ternary complexes. This improvement up 
to 70 and 9 times for ARG and GLU, respectively, suggests a 
significant increase in the complexation efficiency between 
SDZ and βCD by addition of small amounts of aminoac-
ids. According to the NMR data, the formation of inclusion 
complexes is possible through the insertion of the ring A of 
the drug into the βCD cavity.
Fig.4. Scanning electron microphotographs of: (A) SDZ, (B) βCD, (C) GLY, (D) SDZ:βCD:GLY PM, (E) 
SDZ:βCD:GLY CO, (F) SDZ:βCD:GLY FD, (G) ARG (H) SDZ:βCD:ARG PM, (I) SDZ:βCD:ARG CO (J) 
SDZ:βCD:ARG FD, (K) GLU (L) SDZ:βCD:GLU PM, (M) SDZ:βCD:GLU CO and (N) SDZ:βCD:GLU FD.
The use of DSC, TG, and SEM enabled us to thoroughly elu-
cidate the solid-state interactions of SDZ:βCD:AA ternary 
systems and suggested the formation of new solid phases. 
This allowed us to conclude that there are strong evidences 
of ternary inclusion complex formation between SDZ, βCD 
and AA by using freeze-drying and co-evaporation. Taking 
into account these results, we postulate that the interaction 
of SDZ with βCD and AA through the formation of inclu-
sion complexes, effectively enhance the solubility of SDZ, 
which can thus increase its bioavailability and improve its 
pharmaceutical potential.
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